Trial intelligence / Profile preview

Nuan-gong-ye for Primary Dysmenorrhea

NCT06295822Recruiting

Sponsor
China Medical University Hospital
Start
Mar 2024
Primary completion
Aug 2025
Modality
Hydrogel Systems, Transdermal Patches
Countries
1
01

Overview

Randomised, double-blind trial in primary dysmenorrhea (PD) comparing Nuan-gong-ye with Placebo (2 arms). Primary endpoint: Visual Analogue Scale at 4 months. Started Mar 2024; status: recruiting.

02

Drugs

Nuan-gong-ye
03

Conditions

primary dysmenorrhea (PD)

Beyond the preview

Go deeper on NCT06295822.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06295822.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call